Free release
Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)

Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)

CAS No. :27821-45-0MDL No. :MFCD00084679Formula :C9H12N2Na2O12P2Boiling Point :-Linear Structure Formula :-InChI Key :-M

Sales:Service@apichina.com
CAS No. :27821-45-0 Brand :Qitai
Formula :C9H12N2Na2O12P2 M.W :448.12

Introduction

CAS No. :27821-45-0 MDL No. :MFCD00084679
Formula : C9H12N2Na2O12P2 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 448.12 Pubchem ID :-
Synonyms :
UDP disodium salt
Chemical Name :Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen diphosphate

Physicochemical Properties

Num. heavy atoms : 27
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.56
Num. rotatable bonds : 6
Num. H-bond acceptors : 12.0
Num. H-bond donors : 4.0
Molar Refractivity : 73.03
TPSA : 243.12 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -12.38 cm/s

Lipophilicity

Log Po/w (iLOGP) : -41.2
Log Po/w (XLOGP3) : -4.72
Log Po/w (WLOGP) : -2.07
Log Po/w (MLOGP) : -4.52
Log Po/w (SILICOS-IT) : -3.58
Consensus Log Po/w : -11.22

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 1.0
Egan : 1.0
Muegge : 3.0
Bioavailability Score : 0.11

Water Solubility

Log S (ESOL) : 0.59
Solubility : 1730.0 mg/ml ; 3.86 mol/l
Class : Highly soluble
Log S (Ali) : 0.24
Solubility : 781.0 mg/ml ; 1.74 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : 2.46
Solubility : 131000.0 mg/ml ; 292.0 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 4.54
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram: